| Sudershan Singla, MD | |
|
281 Lincoln St, Department Of Anesthesiology, Worcester, MA 01605-2138 | |
| (508) 334-5897 | |
| (508) 334-5179 |
| Full Name | Sudershan Singla |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 46 Years |
| Location | 281 Lincoln St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063497949 | NPI | - | NPPES |
| 110054766A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 77042 (Massachusetts) | Secondary |
| 207L00000X | Anesthesiology | 77042 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umass Memorial Healthcare-marlborough Hospital | Marlborough, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
A history of psychedelic drug use is associated with less psychological distress and fewer suicidal thoughts, planning and attempts, according to new research from Johns Hopkins and the University of Alabama at Birmingham.
Columbia University and Health Fidelity, Inc. announced today that they have entered into a license agreement for commercialization of Columbia's MedLEE Natural Language Processing technology.
PGXL, a Louisville-based molecular diagnostics laboratory, announced a new contractual agreement with Generation Health, Inc. The agreement makes PGXL a preferred genetic testing lab for GH. The lab will provide molecular diagnostic tests for GH, which will help physicians make therapeutic decisions and facilitate what has come to be known as "personalized medicine."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
72% of clinicians believe that Government spending cuts within the NHS increase the risk of hospital acquired infections. The ‘Think C-differently' report, which advises on the current Clostridium difficile landscape, found that despite stringent measures to manage and control Clostridium difficile infection, the NHS is still battling to keep infection rates to a minimum.
› Verified 8 days ago
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
A history of psychedelic drug use is associated with less psychological distress and fewer suicidal thoughts, planning and attempts, according to new research from Johns Hopkins and the University of Alabama at Birmingham.
Columbia University and Health Fidelity, Inc. announced today that they have entered into a license agreement for commercialization of Columbia's MedLEE Natural Language Processing technology.
PGXL, a Louisville-based molecular diagnostics laboratory, announced a new contractual agreement with Generation Health, Inc. The agreement makes PGXL a preferred genetic testing lab for GH. The lab will provide molecular diagnostic tests for GH, which will help physicians make therapeutic decisions and facilitate what has come to be known as "personalized medicine."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
72% of clinicians believe that Government spending cuts within the NHS increase the risk of hospital acquired infections. The ‘Think C-differently' report, which advises on the current Clostridium difficile landscape, found that despite stringent measures to manage and control Clostridium difficile infection, the NHS is still battling to keep infection rates to a minimum.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sudershan Singla, MD Po Box 415348, Boston, MA 02241-5348 Ph: () - | Sudershan Singla, MD 281 Lincoln St, Department Of Anesthesiology, Worcester, MA 01605-2138 Ph: (508) 334-5897 |
News Archive
A history of psychedelic drug use is associated with less psychological distress and fewer suicidal thoughts, planning and attempts, according to new research from Johns Hopkins and the University of Alabama at Birmingham.
Columbia University and Health Fidelity, Inc. announced today that they have entered into a license agreement for commercialization of Columbia's MedLEE Natural Language Processing technology.
PGXL, a Louisville-based molecular diagnostics laboratory, announced a new contractual agreement with Generation Health, Inc. The agreement makes PGXL a preferred genetic testing lab for GH. The lab will provide molecular diagnostic tests for GH, which will help physicians make therapeutic decisions and facilitate what has come to be known as "personalized medicine."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
72% of clinicians believe that Government spending cuts within the NHS increase the risk of hospital acquired infections. The ‘Think C-differently' report, which advises on the current Clostridium difficile landscape, found that despite stringent measures to manage and control Clostridium difficile infection, the NHS is still battling to keep infection rates to a minimum.
› Verified 8 days ago
Layla Fakhrzadeh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Anesthesiology, Worcester, MA 01655 Phone: 508-334-3271 Fax: 508-856-5911 | |
Yoonyie Cho, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
M. Richard Pavao, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Department Of Pain Management, Worcester, MA 01605 Phone: 508-793-6804 Fax: 508-793-6819 | |
Ashley E Gabrielsen, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Dr. Sergio Zendejas, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 281 Lincoln St, Medical Staff Svcs, Worcester, MA 01605 Phone: 508-334-8015 Fax: 508-334-8235 | |
James Savage Iv, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 |